3D Bioprinting Market Key Players
Major players profiled in the 3D bioprinting market report include Cyfuse Biomedical K.K. (Japan), EnvisionTEC GmbH (Germany), Cellink AB (Sweden), Poietis (France), Stratasys Ltd. (US), Aspect Biosystems Ltd. (Canada), Regenovo Biotechnology Co. Ltd. (China), Organovo Holdings Inc. (US), Allevi (US), FUJIFILM Wako Automation Corporation (US), REGENHU Ltd. (Switzerland), and Nano3D Biosciences Inc. (US).
The 3D Bioprinting Market size to attain the a CAGR of 24.59% to get past a valuation of around USD 1,923.02 million by 2023, suggests Market Research Future (MRFR). The growth would get significant mileage with the surging demand for organ transplantation. In the medical sector, prevalent cases of chronic illnesses can make sure that the 3D bioprinting market gains prominent hike. The Global 3D Bioprinting Market Size is relying on not just factors related directly to the market and its growth but incorporates other features as well. This would include 3D printing regenerative medicine, bioink market, and biofabrication market as well.
Various factors are propelling the 3D bioprinting market growth. These factors, as per the new Market Research Future (MRFR) report, include growing geriatric population, increased research and development investments, technological advancements, growing compliance in drug development and discovery, a limited number of organ donors, and increasing cases of chronic diseases. Additional factors pushing market growth include innovations in 3D bioprinting technologies, growing use in cosmetic surgeries and pharmaceutical industries, increasing grants, funds, and investments for research by public-private organizations and an increasing number of organ transplantation.
On the flip side, the scarcity of skilled professionals for operating 3D bioprinting technologies that are technologically advanced may hamper the 3D bioprinting market growth over the forecast period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/869
3D Bioprinting Market Regional Segmaentation
By regions, the global 3D bioprinting market report has significantly noted the contributions made by the Americas, Europe, and Asia Pacific (APAC). The report has also included the Middle East & Africa (MEA) but the region can only have a meagre impact on the market due to the presence of economies that are financially poor.
The Americas can impact the market with its strong infrastructural setup that is receiving ample backing from various investors who are ready to join the wagon to increase their profit margin. The regional market has two distinct segments like North America and South America. In North America, the presence of the US and Canada has a major impact on the market outcome and it can be attributed to the superlative support these countries are receiving from their research and development sector. In Europe, the same features would contribute. Both these regions would benefit from additive manufacturings. The Asia Pacific region is displaying a strong potential to give space to major market players who can explore possibilities for a better growth opportunity. The regional market can establish a strong foothold in the global arena with the fastest CAGR over the review period.
3D Bioprinting Market Segmentation
The MRFR report provides an all-inclusive segmental analysis of the 3D bioprinting market based on end user, application, material, and technology.
Based on technology, the 3D bioprinting market is segmented into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, and microextrusion bioprinting. Of these, the microextrusion bioprinting segment will have the largest share in the market over the forecast period owing to its wide applications in bioprinting.
Based on material, the 3D bioprinting market is segmented into extracellular matrices, hydrogels, and living cells. Of these, the living cells segment will dominate the market over the forecast period owing to the accelerated production process of micro building blocks.
Based on applications, the 3D bioprinting market is segmented into clinical applications and research applications. Of these, the research applications segment will lead the market over the forecast period due to its wide applications in regenerative medicine and 3D cell culture.
Based on end user, the 3D bioprinting market is segmented into research organizations and academic institutes and pharmaceutical and biotechnology companies. Of these, the pharmaceutical and biotechnology institutes will have the maximum share in the market over the forecast period due to the growing trend in personalized medicines.
Browse More Reports at:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.